{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T10:31:38Z","timestamp":1794738698119,"version":"4.9.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM129123"],"award-info":[{"award-number":["R01GM129123"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lynch syndrome (LS) is a cancer predisposition syndrome affecting more than 1 in every 300 individuals worldwide. Clinical genetic testing for LS can be life-saving but is complicated by the heavy burden of variants of uncertain significance (VUS), especially missense changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>\n                      To address this challenge, we leverage a multiplexed analysis of variant effect (MAVE) map covering &gt;94% of the 17,746 possible missense variants in the key LS gene\n                      <jats:italic>MSH2<\/jats:italic>\n                      . To establish this map\u2019s utility in large-scale variant reclassification, we overlay it on clinical databases of &gt;15,000 individuals with LS gene variants uncovered during clinical genetic testing. We validate these functional measurements in a cohort of individuals with paired tumor-normal test results and find that MAVE-based function scores agree with the clinical interpretation for every one of the\n                      <jats:italic>MSH2<\/jats:italic>\n                      missense variants with an available classification. We use these scores to attempt reclassification for 682 unique missense VUS, among which 34 scored as deleterious by our function map, in line with previously published rates for other cancer predisposition genes. Combining functional data and other evidence, ten missense VUS are reclassified as pathogenic\/likely pathogenic, and another 497 could be moved to benign\/likely benign. Finally, we apply these functional scores to paired tumor-normal genetic tests and identify a subset of patients with biallelic somatic loss of function, reflecting a sporadic Lynch-like Syndrome with distinct implications for treatment and relatives\u2019 risk.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study demonstrates how high-throughput functional assays can empower scalable VUS resolution and prospectively generate strong evidence for variant classification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13059-022-02839-z","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T06:37:53Z","timestamp":1671691073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Saturation-scale functional evidence supports clinical variant interpretation in Lynch syndrome"],"prefix":"10.1186","volume":"23","author":[{"given":"Anthony","family":"Scott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Chamberlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachid","family":"Karam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6145-882X","authenticated-orcid":false,"given":"Jacob O.","family":"Kitzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,22]]},"reference":[{"key":"2839_CR1","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1158\/1055-9965.EPI-16-0693","volume":"26","author":"AK Win","year":"2017","unstructured":"Win AK, Jenkins MA, Dowty JG, Antoniou AC, Lee A, Giles GG, et al. Prevalence and penetrance of major genes and polygenes for colorectal cancer. Cancer Epidemiol Biomark Prev. 2017;26:404\u201312.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"2839_CR2","doi-asserted-by":"publisher","first-page":"14755","DOI":"10.1038\/ncomms14755","volume":"8","author":"S Haraldsdottir","year":"2017","unstructured":"Haraldsdottir S, Rafnar T, Frankel WL, Einarsdottir S, Sigurdsson A, Hampel H, et al. Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2. Nat Commun. 2017;8:14755.","journal-title":"Nat Commun"},{"key":"2839_CR3","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1053\/j.gastro.2010.01.054","volume":"138","author":"KW Jasperson","year":"2010","unstructured":"Jasperson KW, Tuohy TM, Neklason DW, Burt RW. Hereditary and familial colon cancer. Gastroenterology. 2010;138:2044\u201358.","journal-title":"Gastroenterology."},{"key":"2839_CR4","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1001\/jama.2012.13088","volume":"308","author":"L Moreira","year":"2012","unstructured":"Moreira L, Balaguer F, Lindor N, de la Chapelle A, Hampel H, Aaltonen LA, et al. Identification of Lynch syndrome among patients with colorectal cancer. JAMA. 2012;308:1555\u201365.","journal-title":"JAMA."},{"key":"2839_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41436-019-0596-9","volume":"22","author":"M Dominguez-Valentin","year":"2019","unstructured":"Dominguez-Valentin M, Sampson JR, Sepp\u00e4l\u00e4 TT, ten Broeke SW, Plazzer J-P, Nakken S, et al. Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database. Genet Med. 2019;22:15\u201325.","journal-title":"Genet Med"},{"key":"2839_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1158\/1940-6207.CAPR-10-0345","volume":"4","author":"H Hampel","year":"2011","unstructured":"Hampel H, de la Chapelle A. The search for unaffected individuals with Lynch syndrome: do the ends justify the means? Cancer Prev Res. 2011;4:1\u20135.","journal-title":"Cancer Prev Res"},{"key":"2839_CR7","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/jmg.2010.077677","volume":"47","author":"W Sjursen","year":"2010","unstructured":"Sjursen W, Haukanes BI, Grindedal EM, Aarset H, Stormorken A, Engebretsen LF, et al. Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers. J Med Genet. 2010;47:579\u201385.","journal-title":"J Med Genet"},{"key":"2839_CR8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41436-019-0633-8","volume":"22","author":"H LaDuca","year":"2020","unstructured":"LaDuca H, Polley EC, Yussuf A, Hoang L, Gutierrez S, Hart SN, et al. A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients. Genet Med. 2020;22:407\u201315.","journal-title":"Genet Med"},{"key":"2839_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10689-013-9629-8","volume":"12","author":"RH Sijmons","year":"2013","unstructured":"Sijmons RH, Greenblatt MS, Genuardi M. Gene variants of unknown clinical significance in Lynch syndrome. An introduction for clinicians. Familial Cancer. 2013;12:181\u20137.","journal-title":"Familial Cancer"},{"key":"2839_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/humu.23117","volume":"38","author":"R Tricarico","year":"2017","unstructured":"Tricarico R, Kasela M, Mareni C, Thompson BA, Drouet A, Staderini L, et al. Assessment of the InSiGHT Interpretation Criteria for the Clinical Classification of 24 MLH1 and MSH2 Gene Variants. Hum Mutat. 2017;38:64\u201377.","journal-title":"Hum Mutat"},{"key":"2839_CR11","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1001\/jama.2018.13152","volume":"320","author":"J Mersch","year":"2018","unstructured":"Mersch J, Brown N, Pirzadeh-Miller S, Mundt E, Cox HC, Brown K, et al. Prevalence of variant reclassification following hereditary cancer genetic testing. JAMA. 2018;320:1266\u201374.","journal-title":"JAMA."},{"key":"2839_CR12","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1245\/s10434-017-5959-3","volume":"24","author":"JL Welsh","year":"2017","unstructured":"Welsh JL, Hoskin TL, Day CN, Thomas AS, Cogswell JA, Couch FJ, et al. Clinical decision-making in patients with variant of uncertain significance in BRCA1 or BRCA2 Genes. Ann Surg Oncol. 2017;24:3067\u201372.","journal-title":"Ann Surg Oncol"},{"key":"2839_CR13","doi-asserted-by":"crossref","unstructured":"Hampel H, Yurgelun MB. Point\/counterpoint: is it time for universal germline genetic testing for all GI cancers? J Clin Oncol. 2022:JCO2102764.","DOI":"10.1200\/JCO.21.02764"},{"key":"2839_CR14","doi-asserted-by":"publisher","unstructured":"Backwell L, Marsh JA. Diverse molecular mechanisms underlying pathogenic protein mutations: beyond the loss-of-function paradigm. Annu Rev Genomics Hum Genet. 2022. https:\/\/doi.org\/10.1146\/annurev-genom-111221-103208.","DOI":"10.1146\/annurev-genom-111221-103208"},{"key":"2839_CR15","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46:D1062\u20137.","journal-title":"Nucleic Acids Res"},{"key":"2839_CR16","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41379-019-0414-6","volume":"33","author":"JF Hechtman","year":"2020","unstructured":"Hechtman JF, Rana S, Middha S, Stadler ZK, Latham A, Benayed R, et al. Retained mismatch repair protein expression occurs in approximately 6% of microsatellite instability-high cancers and is associated with missense mutations in mismatch repair genes. Mod Pathol. 2020;33:871\u20139.","journal-title":"Mod Pathol"},{"key":"2839_CR17","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00439-018-1916-x","volume":"137","author":"J Weile","year":"2018","unstructured":"Weile J, Roth FP. Multiplexed assays of variant effects contribute to a growing genotype-phenotype atlas. Hum Genet. 2018;137:665\u201378.","journal-title":"Hum Genet"},{"key":"2839_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ajhg.2017.07.014","volume":"101","author":"LM Starita","year":"2017","unstructured":"Starita LM, Ahituv N, Dunham MJ, Kitzman JO, Roth FP, Seelig G, et al. Variant interpretation: functional assays to the rescue. Am J Hum Genet. 2017;101:315\u201325.","journal-title":"Am J Hum Genet"},{"key":"2839_CR19","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20199380","volume":"16","author":"BJ Livesey","year":"2020","unstructured":"Livesey BJ, Marsh JA. Using deep mutational scanning to benchmark variant effect predictors and identify disease mutations. Mol Syst Biol. 2020;16:e9380.","journal-title":"Mol Syst Biol"},{"key":"2839_CR20","doi-asserted-by":"publisher","unstructured":"Cubuk C, Garrett A, Choi S, King L, Loveday C, Torr B, et al. Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes. Genet Med. 2021. https:\/\/doi.org\/10.1038\/s41436-021-01265-z.","DOI":"10.1038\/s41436-021-01265-z"},{"key":"2839_CR21","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1016\/j.ajhg.2021.11.001","volume":"108","author":"S Fayer","year":"2021","unstructured":"Fayer S, Horton C, Dines JN, Rubin AF, Richardson ME, McGoldrick K, et al. Closing the gap: Systematic integration of multiplexed functional data resolves variants of uncertain significance in BRCA1, TP53, and PTEN. Am J Hum Genet. 2021;108:2248\u201358.","journal-title":"Am J Hum Genet"},{"key":"2839_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13073-019-0698-7","volume":"11","author":"H Gelman","year":"2019","unstructured":"Gelman H, Dines JN, Berg J, Berger AH, Brnich S, Hisama FM, et al. Recommendations for the collection and use of multiplexed functional data for clinical variant interpretation. Genome Med. 2019;11:85.","journal-title":"Genome Med"},{"key":"2839_CR23","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/humu.23609","volume":"39","author":"SE Brnich","year":"2018","unstructured":"Brnich SE, Rivera-Mu\u00f1oz EA, Berg JS. Quantifying the potential of functional evidence to reclassify variants of uncertain significance in the categorical and Bayesian interpretation frameworks. Hum Mutat. 2018;39:1531\u201341.","journal-title":"Hum Mutat"},{"key":"2839_CR24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41586-018-0461-z","volume":"562","author":"GM Findlay","year":"2018","unstructured":"Findlay GM, Daza RM, Martin B, Zhang MD, Leith AP, Gasperini M, et al. Accurate classification of BRCA1 variants with saturation genome editing. Nature. 2018;562:217\u201322.","journal-title":"Nature."},{"key":"2839_CR25","volume":"3","author":"KM Schiabor Barrett","year":"2022","unstructured":"Schiabor Barrett KM, Masnick M, Hatchell KE, Savatt JM, Banet N, Buchanan A, et al. Clinical validation of genomic functional screen data: analysis of observed BRCA1 variants in an unselected population cohort. HGG Adv. 2022;3:100086.","journal-title":"HGG Adv"},{"key":"2839_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ajhg.2020.12.003","volume":"108","author":"X Jia","year":"2021","unstructured":"Jia X, Burugula BB, Chen V, Lemons RM, Jayakody S, Maksutova M, et al. Massively parallel functional testing of MSH2 missense variants conferring Lynch syndrome risk. Am J Hum Genet. 2021;108:163\u201375.","journal-title":"Am J Hum Genet"},{"key":"2839_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13073-019-0690-2","volume":"12","author":"SE Brnich","year":"2019","unstructured":"Brnich SE, Abou Tayoun AN, Couch FJ, Cutting GR, Greenblatt MS, Heinen CD, et al. Recommendations for application of the functional evidence PS3\/BS3 criterion using the ACMG\/AMP sequence variant interpretation framework. Genome Med. 2019;12:3.","journal-title":"Genome Med"},{"key":"2839_CR28","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/gim.2017.210","volume":"20","author":"SV Tavtigian","year":"2018","unstructured":"Tavtigian SV, Greenblatt MS, Harrison SM, Nussbaum RL, Prabhu SA, Boucher KM, et al. Modeling the ACMG\/AMP variant classification guidelines as a Bayesian classification framework. Genet Med. 2018;20:1054\u201360.","journal-title":"Genet Med"},{"key":"2839_CR29","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S1535-6108(02)00073-9","volume":"1","author":"CD Heinen","year":"2002","unstructured":"Heinen CD, Wilson T, Mazurek A, Berardini M, Butz C, Fishel R. HNPCC mutations in hMSH2 result in reduced hMSH2-hMSH6 molecular switch functions. Cancer Cell. 2002;1:469\u201378.","journal-title":"Cancer Cell"},{"key":"2839_CR30","doi-asserted-by":"publisher","unstructured":"Chao EC, Velasquez JL, Witherspoon MS, Rozek LS, Peel D, Ng P, Gruber SB, Watson P, Rennert G, Anton-Culver H, Lynch H, Lipkin SM. Accurate classification of MLH1\/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR). Hum Mutat. 2008;29(6):852-60. https:\/\/doi.org\/10.1002\/humu.20735.","DOI":"10.1002\/humu.20735"},{"key":"2839_CR31","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1136\/gutjnl-2017-314057","volume":"67","author":"P M\u00f8ller","year":"2018","unstructured":"M\u00f8ller P, Sepp\u00e4l\u00e4 TT, Bernstein I, Holinski-Feder E, Sala P, Gareth Evans D, et al. Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database. Gut. 2018;67:1306\u201316.","journal-title":"Gut."},{"key":"2839_CR32","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/gcc.20678","volume":"48","author":"RC Niessen","year":"2009","unstructured":"Niessen RC, Hofstra RMW, Westers H, Ligtenberg MJL, Kooi K, Jager POJ, et al. Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome. Genes Chromosom Cancer. 2009;48:737\u201344.","journal-title":"Genes Chromosom Cancer"},{"key":"2839_CR33","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/ng.283","volume":"41","author":"MJL Ligtenberg","year":"2009","unstructured":"Ligtenberg MJL, Kuiper RP, Chan TL, Goossens M, Hebeda KM, Voorendt M, et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3\u2019 exons of TACSTD1. Nat Genet. 2009;41:112\u20137.","journal-title":"Nat Genet"},{"key":"2839_CR34","first-page":"5248","volume":"58","author":"CR Boland","year":"1998","unstructured":"Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58:5248\u201357.","journal-title":"Cancer Res"},{"key":"2839_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ajhg.2018.05.001","volume":"103","author":"BH Shirts","year":"2018","unstructured":"Shirts BH, Konnick EQ, Upham S, Walsh T, Ranola JMO, Jacobson AL, et al. Using somatic mutations from tumors to classify variants in mismatch repair genes. Am J Hum Genet. 2018;103:19\u201329.","journal-title":"Am J Hum Genet"},{"key":"2839_CR36","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI, et al. Predicting splicing from primary sequence with deep learning. Cell. 2019;176:535\u2013548.e24.","journal-title":"Cell."},{"key":"2839_CR37","doi-asserted-by":"publisher","unstructured":"Dominguez-Valentin M, Plazzer J-P, Sampson JR, Engel C, Aretz S, Jenkins MA, et al. No difference in penetrance between truncating and missense\/aberrant splicing pathogenic variants in MLH1 and MSH2: a Prospective Lynch Syndrome Database Study. J Clin Med Res. 2021:10. https:\/\/doi.org\/10.3390\/jcm10132856.","DOI":"10.3390\/jcm10132856"},{"key":"2839_CR38","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1038\/s41467-020-17374-3","volume":"11","author":"AC Fahed","year":"2020","unstructured":"Fahed AC, Wang M, Homburger JR, Patel AP, Bick AG, Neben CL, et al. Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions. Nat Commun. 2020;11:3635.","journal-title":"Nat Commun"},{"key":"2839_CR39","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1073\/pnas.68.4.820","volume":"68","author":"AG Knudson Jr","year":"1971","unstructured":"Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971;68:820\u20133.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2839_CR40","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s10689-013-9688-x","volume":"13","author":"J Rhees","year":"2014","unstructured":"Rhees J, Arnold M, Boland CR. Inversion of exons 1-7 of the MSH2 gene is a frequent cause of unexplained Lynch syndrome in one local population. Familial Cancer. 2014;13:219\u201325.","journal-title":"Familial Cancer"},{"key":"2839_CR41","doi-asserted-by":"publisher","first-page":"4988","DOI":"10.1038\/ncomms5988","volume":"5","author":"CC Pritchard","year":"2014","unstructured":"Pritchard CC, Morrissey C, Kumar A, Zhang X, Smith C, Coleman I, et al. Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer. Nat Commun. 2014;5:4988.","journal-title":"Nat Commun"},{"key":"2839_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007231","volume":"14","author":"CL Rhine","year":"2018","unstructured":"Rhine CL, Cygan KJ, Soemedi R, Maguire S, Murray MF, Monaghan SF, et al. Hereditary cancer genes are highly susceptible to splicing mutations. PLoS Genet. 2018;14:e1007231.","journal-title":"PLoS Genet"},{"key":"2839_CR43","doi-asserted-by":"crossref","unstructured":"Morak M, Pineda M, Martins A, Gaildrat P, Tubeuf H, Drouet A, et al. Splicing analyses for variants in MMR genes: best practice recommendations from the European Mismatch Repair Working Group. Eur J Hum Genet. 2022:1\u20139.","DOI":"10.1038\/s41431-022-01106-w"},{"key":"2839_CR44","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s41587-021-01201-1","volume":"40","author":"S Erwood","year":"2022","unstructured":"Erwood S, Bily TMI, Lequyer J, Yan J, Gulati N, Brewer RA, et al. Saturation variant interpretation using CRISPR prime editing. Nat Biotechnol. 2022;40:885\u201395.","journal-title":"Nat Biotechnol"},{"key":"2839_CR45","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1016\/j.ajhg.2021.06.013","volume":"108","author":"P Gergics","year":"2021","unstructured":"Gergics P, Smith C, Bando H, Jorge AAL, Rockstroh-Lippold D, Vishnopolska SA, et al. High-throughput splicing assays identify missense and silent splice-disruptive POU1F1 variants underlying pituitary hormone deficiency. Am J Hum Genet. 2021;108:1526\u201339.","journal-title":"Am J Hum Genet"},{"key":"2839_CR46","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13059-018-1437-x","volume":"19","author":"SI Adamson","year":"2018","unstructured":"Adamson SI, Zhan L, Graveley BR. Vex-seq: high-throughput identification of the impact of genetic variation on pre-mRNA splicing efficiency. Genome Biol. 2018;19:71.","journal-title":"Genome Biol"},{"key":"2839_CR47","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/ng.3837","volume":"49","author":"R Soemedi","year":"2017","unstructured":"Soemedi R, Cygan KJ, Rhine CL, Wang J, Bulacan C, Yang J, et al. Pathogenic variants that alter protein code often disrupt splicing. Nat Genet. 2017;49:848\u201355.","journal-title":"Nat Genet"},{"key":"2839_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13073-021-00835-9","volume":"13","author":"P Rentzsch","year":"2021","unstructured":"Rentzsch P, Schubach M, Shendure J, Kircher M. CADD-Splice-improving genome-wide variant effect prediction using deep learning-derived splice scores. Genome Med. 2021;13:31.","journal-title":"Genome Med"},{"key":"2839_CR49","doi-asserted-by":"publisher","first-page":"2469523","DOI":"10.1155\/2016\/2469523","volume":"2016","author":"T Pesaran","year":"2016","unstructured":"Pesaran T, Karam R, Huether R, Li S, Farber-Katz S, Chamberlin A, et al. Beyond DNA: an integrated and functional approach for classifying germline variants in breast cancer genes. Int J Breast Cancer. 2016;2016:2469523.","journal-title":"Int J Breast Cancer"},{"key":"2839_CR50","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"2839_CR51","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.ajhg.2017.11.004","volume":"101","author":"S Martin","year":"2017","unstructured":"Martin S, Chamberlin A, Shinde DN, Hempel M, Strom TM, Schreiber A, et al. De novo variants in GRIA4 lead to intellectual disability with or without seizures and gait abnormalities. Am J Hum Genet. 2017;101:1013\u201320.","journal-title":"Am J Hum Genet"},{"key":"2839_CR52","doi-asserted-by":"publisher","unstructured":"Sherrill JD, Kc K, Wang X, Wen T, Chamberlin A, Stucke EM, et al. Whole-exome sequencing uncovers oxidoreductases DHTKD1 and OGDHL as linkers between mitochondrial dysfunction and eosinophilic esophagitis. JCI Insight. 2018:3. https:\/\/doi.org\/10.1172\/jci.insight.99922.","DOI":"10.1172\/jci.insight.99922"},{"key":"2839_CR53","doi-asserted-by":"crossref","unstructured":"Seabold S, Perktold J. Statsmodels: Econometric and statistical modeling with python. Proceedings of the 9th Python in Science Conference [Internet]. SciPy; 2010. Available from: https:\/\/conference.scipy.org\/proceedings\/scipy2010\/seabold.html.","DOI":"10.25080\/Majora-92bf1922-011"}],"container-title":["Genome Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13059-022-02839-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13059-022-02839-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13059-022-02839-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T10:07:50Z","timestamp":1685614070000},"score":1,"resource":{"primary":{"URL":"https:\/\/genomebiology.biomedcentral.com\/articles\/10.1186\/s13059-022-02839-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2839"],"URL":"https:\/\/doi.org\/10.1186\/s13059-022-02839-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.08.08.22278549","asserted-by":"object"}]},"ISSN":["1474-760X"],"issn-type":[{"value":"1474-760X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,22]]},"assertion":[{"value":"15 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data collection and sharing procedures were reviewed by the Western IRB and University of Michigan Medical School IRB (study HUM00220511) and declared exempt from human subject regulations. All experimental methods comply with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"F.H., A.C., and R.K. are employees of Ambry Genetics. J.O.K. serves as a scientific advisor to MyOme, Inc. The authors declare that there are no further competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"266"}}